These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 29693166)
1. Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1α activation. Yang X; Yin H; Zhang Y; Li X; Tong H; Zeng Y; Wang Q; He W Int J Oncol; 2018 Jul; 53(1):215-224. PubMed ID: 29693166 [TBL] [Abstract][Full Text] [Related]
2. Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101). Mani J; Vallo S; Rakel S; Antonietti P; Gessler F; Blaheta R; Bartsch G; Michaelis M; Cinatl J; Haferkamp A; Kögel D BMC Cancer; 2015 Apr; 15():224. PubMed ID: 25885284 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia-mediated attenuation of EGLN2 inhibition of the NF-κB signaling pathway leads to the formation of a loop between HIF-1α and MUC1-C promoting chemoresistance in bladder cancer. Qing L; Li Q; Yang Y; Xu W; Wang Y; Li R; You C; Dong Z Mol Carcinog; 2024 Jul; 63(7):1303-1318. PubMed ID: 38634741 [TBL] [Abstract][Full Text] [Related]
4. BNIP3-mediated Autophagy Induced Inflammatory Response and Inhibited VEGF Expression in Cultured Retinal Pigment Epithelium Cells Under Hypoxia. Chen Y; Yan Q; Xu Y; Ye F; Sun X; Zhu H; Wang H Curr Mol Med; 2019; 19(6):395-404. PubMed ID: 31072291 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia-Induced Autophagy Enhances Cisplatin Resistance in Human Bladder Cancer Cells by Targeting Hypoxia-Inducible Factor-1 Mao X; Nanzhang ; Xiao J; Wu H; Ding K J Immunol Res; 2021; 2021():8887437. PubMed ID: 33681390 [TBL] [Abstract][Full Text] [Related]
6. Gemcitabine-Induced Autophagy Protects Human Lung Cancer Cells from Apoptotic Death. Wu HM; Shao LJ; Jiang ZF; Liu RY Lung; 2016 Dec; 194(6):959-966. PubMed ID: 27604425 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells. He X; Wang J; Wei W; Shi M; Xin B; Zhang T; Shen X Cancer Biol Ther; 2016; 17(2):188-98. PubMed ID: 26785721 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of AMPK by 4-O-methylascochlorin promotes autophagy via the HIF-1α expression. Seok JY; Jeong YJ; Hwang SK; Kim CH; Magae J; Chang YC J Cell Mol Med; 2018 Dec; 22(12):6345-6356. PubMed ID: 30338933 [TBL] [Abstract][Full Text] [Related]
9. HIF-1α/Beclin1-Mediated Autophagy Is Involved in Neuroprotection Induced by Hypoxic Preconditioning. Lu N; Li X; Tan R; An J; Cai Z; Hu X; Wang F; Wang H; Lu C; Lu H J Mol Neurosci; 2018 Oct; 66(2):238-250. PubMed ID: 30203298 [TBL] [Abstract][Full Text] [Related]
10. PTBP3 promotes malignancy and hypoxia-induced chemoresistance in pancreatic cancer cells by ATG12 up-regulation. Ma J; Weng L; Jia Y; Liu B; Wu S; Xue L; Yin X; Mao A; Wang Z; Shang M J Cell Mol Med; 2020 Mar; 24(5):2917-2930. PubMed ID: 31989778 [TBL] [Abstract][Full Text] [Related]
11. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway. Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522 [TBL] [Abstract][Full Text] [Related]
12. Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer. Akada M; Crnogorac-Jurcevic T; Lattimore S; Mahon P; Lopes R; Sunamura M; Matsuno S; Lemoine NR Clin Cancer Res; 2005 Apr; 11(8):3094-101. PubMed ID: 15837765 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. Pan J; Li X; Wu W; Xue M; Hou H; Zhai W; Chen W Cancer Lett; 2016 Nov; 382(1):64-76. PubMed ID: 27591936 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells. Huang YT; Cheng CC; Lin TC; Chiu TH; Lai PC Oncol Rep; 2014 Feb; 31(2):771-80. PubMed ID: 24297644 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia suppresses myocardial survival pathway through HIF-1α-IGFBP-3-dependent signaling and enhances cardiomyocyte autophagic and apoptotic effects mainly via FoxO3a-induced BNIP3 expression. Feng CC; Lin CC; Lai YP; Chen TS; Marthandam Asokan S; Lin JY; Lin KH; Viswanadha VP; Kuo WW; Huang CY Growth Factors; 2016 Aug; 34(3-4):73-86. PubMed ID: 27366871 [TBL] [Abstract][Full Text] [Related]
16. CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated. Yin L; Liu S; Li C; Ding S; Bi D; Niu Z; Han L; Li W; Gao D; Liu Z; Lu J Tumour Biol; 2016 Sep; 37(9):12731-12742. PubMed ID: 27448305 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced autophagy contributes to the invasion of salivary adenoid cystic carcinoma through the HIF-1α/BNIP3 signaling pathway. Wu H; Huang S; Chen Z; Liu W; Zhou X; Zhang D Mol Med Rep; 2015 Nov; 12(5):6467-74. PubMed ID: 26323347 [TBL] [Abstract][Full Text] [Related]
18. Naringin protects H9C2 cardiomyocytes from chemical hypoxia‑induced injury by promoting the autophagic flux via the activation of the HIF‑1α/BNIP3 signaling pathway. Li S; Jiang J; Fang J; Li X; Huang C; Liang W; Wu K Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907819 [TBL] [Abstract][Full Text] [Related]
19. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells. Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818 [TBL] [Abstract][Full Text] [Related]
20. The cytoprotective role of gemcitabine-induced autophagy associated with apoptosis inhibition in triple-negative MDA-MB-231 breast cancer cells. Chen M; He M; Song Y; Chen L; Xiao P; Wan X; Dai F; Shen P Int J Mol Med; 2014 Jul; 34(1):276-82. PubMed ID: 24804820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]